TWIST2 (NM_057179) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC205006L1V
- LentiORF®
Lenti ORF particles, TWIST2 (Myc-DDK tagged) - Human twist homolog 2 (Drosophila) (TWIST2), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 7,410.00
货期*
详询
规格
Product images
经常一起买 (3)
TWIST2 mouse monoclonal antibody, clone OTI6H10 (formerly 6H10)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | TWIST2 (NM_057179) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | AMS; BBRSAY; bHLHa39; DERMO1; FFDD3; SETLSS |
Vector | pLenti-C-Myc-DDK |
ACCN | NM_057179 |
ORF Size | 480 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC205006).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_057179.1 |
RefSeq Size | 1186 bp |
RefSeq ORF | 483 bp |
Locus ID | 117581 |
Protein Families | Druggable Genome, Transcription Factors |
MW | 18.1 kDa |
Gene Summary | The protein encoded by this gene is a basic helix-loop-helix type transcription factor and shares similarity with Twist. This protein may inhibit osteoblast maturation and maintain cells in a preosteoblast phenotype during osteoblast development. This gene may be upregulated in certain cancers. Mutations in this gene cause focal facial dermal dysplasia 3, Setleis type. Two transcript variants encoding the same protein have been found. [provided by RefSeq, Apr 2014] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...